Agent based modeling of atherosclerosis: A concrete help in personalized treatments

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 5755 LNAI, Issue , 2009, Pages 386-396

  Pappalardo, Francesco ^a,b   Cincotti, Alessandro ^c   Motta, Alfredo ^d   Pennisi, Marzio ^b  

^a CNR   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^d POLITECNICO DI MILANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGENT-BASED MODEL; AGENT-BASED MODELING; ALCOHOLIC DRINKS; ARTERIAL BLOOD; ATHEROGENESIS; CLINICAL DATA; CLINICAL SITUATIONS; CONCENTRATION OF; DEVELOPED COUNTRIES; IRREVERSIBLE DAMAGE; LDL OXIDATION; LIFE STYLES; LOW DENSITY LIPOPROTEINS; MEDICAL DOCTORS; SHORT PERIODS; SIMULATED PATIENTS; STATINS; VIRTUAL PATIENTS;

BEVERAGES; BLOOD VESSELS; COMPUTER SCIENCE; CONCENTRATION (PROCESS); RISK PERCEPTION;

INTELLIGENT COMPUTING;

EID: 70350430510     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-642-04020-7_41     Document Type: Conference Paper

References (20)

1. Abbas, A.K., Lichtman, A.H., Pillai, S.: Cellular and molecular immunology, 6th edn. Saunders, Philadelphia (2007)
2. Artieda, M., Cenarro, A., Gañàn, A., Jericó, I., Gonzalvo, C., Casado, J.M., Vitoria, I., Puzo, J., Pocoví, M., Civeira, F.: Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler. Thromb. Vasc. Biol. 23, 1645-1652 (2003)
3. Artieda, M., Cenarro, A., Gańàn, A., Lukic, A., Moreno, E., Puzo, J., Pocoví, M., Civeira, F.: Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-Reactive Protein. Cardiology 108, 297-306 (2007)
4. Berliner, J.A., Heinecke, J.W.: The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20(5), 707-727 (1999)
5. Brizzi, P., Isaja, T., D'Agata, A., Malaguarnera, A., Malaguarnera, M., Musumeci, S.: Oxidized LDL antibodies (OLAB) in patients with beta-thalassemia major. J. Atheroscler. Thromb. 9(3), 139-144 (2002)
6. Brizzi, P., Tonolo, G., Carusillo, F., Malaguarnera, M., Maioli, M., Musumeci, S.: Plasma Lipid Composition and LDL Oxidation. Clin. Chem. Lab. Med. 41(1), 56-60 (2003)
7. Brizzi, P., Tonolo, G., Bertrand, G., Carusillo, F., Severino, C., Maioli, M., Malaguarnera, L., Musumeci, S.: Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status. Clin. Chem. Lab. Med. 42(2), 164-170 (2004)
8. Hanson, G.K.: Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352(16), 1685-1695 (2005)
9. Klimov, A.N., Nikulćheva, N.G.: Lipid and Lipoprotein Metabolism and Its Disturbances. Piter Kom, St. Petersburg (1999)
10. Law, M.R.,Wald, N.J., Rudnicka, A.R.: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326(7404), 1423 (2003)
11. Orem, C., Orem, A., Uydu, H.A., Celik, S., Erdol, C., Kural, B.V.: The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status. Coron. Artery Dis. 13(1), 56-71 (2002)
12. Pappalardo, F., Musumeci, S., Motta, S.: Modeling immune system control of atherogenesis. Bioinformatics 24(15), 1715-1721 (2008)
13. Romero-Corral, A., Somers, V.K., Korinek, J., Sierra-Johnson, J., Thomas, R.J., Allison, T.G., Lopez-Jimenez, F.: Update in prevention of atherosclerotic heart disease: management of major cardiovascular risk factors. Rev. Invest. Clin. 58(3), 237-244 (2006)
14. Ross, R.: Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340(2), 115-126 (1999)
15. Shaw, P.X., Hörkkö, S., Tsimikas, S., Chang, M.K., Palinski, W., Silverman, G.J., Chen, P.P., Witztum, J.L.: Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.t Arterioscler. Thromb. Vasc. Biol. 21(8), 1333-1339 (2001)
16. Shoji, T., Nishizawa, Y., Fukumoto, M., Shimamura, K., Kimura, J., Kanda, H., Emoto, M., Kawagishi, T., Morii, H.: Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148(1), 171-177 (2000)
17. Steinberg, D.: Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272(34), 20963-20966 (1997)
18. Tinahones, F.J., Gomez-Zumaquero, J.M., Rojo-Martinez, G., Cardona, F.,Esteva de Antonio, I.E., Ruiz de Adana, M.S., Soriguer, F.K.: Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism 51(4), 429-431 (2002)
19. Tinahones, F.J., Gomez-Zumaquero, J.M., Garrido-Sanchez, L., Garcia-Fuentes, E., Rojo-Martinez, G., Esteva, I., Ruiz de Adana, M.S., Cardona, F., Soriguer, F.: Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J. Lipid Res. 46(3), 452-457 (2005)
20. Vinereanu, D.: Risk factors for atherosclerotic disease: present and future. Herz, Suppl. 3, 5-24 (2006)